Sapropterin dihydrochloride (6R-BH4 dihydrochloride)
(Synonyms: 盐酸沙丙蝶呤; (6R)-BH4 dihydrochloride; (6R)-Tetrahydro-L-biopterin dihydrochloride) 目录号 : GC32438
Sapropterin dihydrochloride (6R-BH4 dihydrochloride)是四氢生物蝶呤活性6R异构体的合成制剂，可有效降低血液苯丙氨酸水平。
Cas No.:69056-38-8
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Sapropterin dihydrochloride (6R-BH4 dihydrochloride), a synthetic formulation of the active 6R isoform of tetrahydrobiopterin, is effective in reducing blood phenylalanine levels[1]. Sapropterin dihydrochloride has been widely used in the treatment of hyperphenylalaninemia[2].
In vitro, Sapropterin dihydrochloride treatment (100μM; 24h) prevented estrogen-stimulated oxidant generation and superoxide production in diabetic patient-derived coronary endothelial cells[3].
In vivo, Sapropterin dihydrochloride treatment (10 mg/kg/day; p.o.) for 20 days in diabetic adult female C57BL/6 mice can increase eNOS activity and reduce oxidative stress in fetal heart, and reduce coronary artery malformations in offspring with pregestational diabetes[4]. In mice with autoimmune encephalomyelitis (EAE), treatment with Sapropterin dihydrochloride for 20 days (2mg/kg/day; p.o), which aggravated EAE in mice, accompanied by increased plasma levels of medium and long-chain ceramides and decreased levels of polyunsaturated fatty acid linolenic acid (FA18:3)[5]. Oral administration of Sapropterin dihydrochloride at the dose of 20mg/kg/day for one week improved pulmonary hypertension induced by chronic hypoxia in newborn pigs[6]. Oral administration of Sapropterin dihydrochloride (100mg/kg/day) for 4 days improved monoamine neurotransmitter turnover and stimulated synaptic neurotransmitter release and subsequent metabolism in mice with phenylketonuria[7].
References:
[1] Sanford M, Keating G M. Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia[J]. Drugs, 2009, 69: 461-476.
[2] Lachmann R. Sapropterin hydrochloride: Enzyme enhancement therapy for phenylketonuria[J]. Therapeutic Advances in Endocrinology and Metabolism, 2011, 2(3): 127-133.
[3] Winkler J, Ma H, Zhu S, et al. Estrogen-induced Superoxide Production in Coronary Artery Endothelial Cells via Uncoupled Nitric Oxide Synthase in Diabetes[J]. The FASEB Journal, 2016, 30: 716.3-716.3.
[4] Engineer A, Lim Y J, Lu X, et al. Sapropterin reduces coronary artery malformation in offspring of pregestational diabetes mice[J]. Nitric Oxide, 2020, 94: 9-18.
[5] Schmitz K, Trautmann S, Hahnefeld L, et al. Sapropterin (BH4) aggravates autoimmune encephalomyelitis in mice[J]. Neurotherapeutics, 2021, 18(3): 1862-1879.
[6] Dikalova A, Aschner J L, Kaplowitz M R, et al. Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2016, 311(4): L743-L753.
[7] Winn S R, Scherer T, Thöny B, et al. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU)[J]. Molecular genetics and metabolism, 2016, 117(1): 5-11.
Sapropterin dihydrochloride (6R-BH4 dihydrochloride)是四氢生物蝶呤活性6R异构体的合成制剂，可有效降低血液苯丙氨酸水平[1]。Sapropterin dihydrochloride已广泛应用于高苯丙氨酸血症的治疗[2]。
在体外，100μM浓度的Sapropterin dihydrochloride处理24小时，能抑制糖尿病患者来源的冠状动脉内皮细胞中由雌激素刺激的活性氧生成及超氧化物产生[3]。
在体内，Sapropterin dihydrochloride处理（10mg/kg/day；p.o.）妊娠期糖尿病成年雌性C57BL/6小鼠20天后，可提升胎儿心脏eNOS活性、减轻氧化应激，并降低子代冠状动脉畸形发生率[4]。Sapropterin dihydrochloride处理（2mg/kg/day；p.o.）20天后导致自身免疫性脑脊髓炎（EAE）小鼠病情加重，伴随血浆中长链神经酰胺水平升高及多不饱和脂肪酸亚麻酸（FA18:3）水平降低[5]。Sapropterin dihydrochloride经口服给药（20mg/kg/day）处理一周后可改善新生小猪中由慢性缺氧诱导的肺动脉高压[6]。Sapropterin dihydrochloride经口服给药（20mg/kg/day）处理4天后导致苯丙酮尿症小鼠中单胺类神经递质代谢改善，突触神经递质释放及后续代谢活动增强[7]。
| Animal experiment [1]: | |
Animal models | C57BL6-Pahenu2/enu2 mice (Pah −/−) |
Preparation Method | Sapropterin dihydrochloride was administered by oral gavage to hyperphenylalaninemic C57BL6-Pahenu2/enu2 mice (Pah −/−) to assess BH4 entry into the brain and the effect of BH4 enteral injection on brain monoamine neurotransmitter content. Mice received Sapropterin dihydrochloride (20, 40, and 100mg/kg/day) via oral gavage (p.o.) for four days. During this period, mice received standard chow (21% protein by weight) and water AD libitum. On the fifth day, mice were euthanized at various time points after Saproterin dihydrochloride treatent for tissue collection. During the time period between Saproterin dihydrochloride treatment and euthanasia, chow feeding was stopped to minimize feeding-induced changes in blood amino acid concentrations. Mice were sedate using inhaled isoflurane anesthesia. Whole blood was collected by cardiac puncture, allowed to coagulate in an Eppendorf tube, and serum was separated by centrifugation. Mice were then euthanized by exsanguination and perfused with 20 ml of normal saline through the left ventricle to remove blood from the cerebral circulation. After decapitation, the entire brain was quickly cut from the skull, split along the sagittal plane, and immediately immersed in liquid nitrogen. Half brain and serum samples were stored at −80 °C until amino acid or neurotransmitter analyses were performed. |
Dosage form | 20, 40, and 100mg/kg/day for 4 days; p.o. |
Applications | Sapropterin dihydrochloride treatment improves monoamine neurotransmitter turnover in murine phenylketonuria. |
References: | |
| Cas No. | 69056-38-8 | SDF | |
| 别名 | 盐酸沙丙蝶呤; (6R)-BH4 dihydrochloride; (6R)-Tetrahydro-L-biopterin dihydrochloride | ||
| Canonical SMILES | O=C1N=C(N)NC2=C1N[C@@H]([C@@H](O)[C@@H](O)C)CN2.[H]Cl.[H]Cl | ||
| 分子式 | C9H17Cl2N5O3 | 分子量 | 314.17 |
| 溶解度 | DMSO : 63mg/mL, Water : 34 mg/mL | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.183 mL | 15.915 mL | 31.8299 mL |
| 5 mM | 0.6366 mL | 3.183 mL | 6.366 mL |
| 10 mM | 0.3183 mL | 1.5915 mL | 3.183 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet